Study reveals higher mortality risk from lung and hematologic neoplasms in rheumatoid arthritis patients
BLISS-BELIEVE study on sequential belimumab and rituximab in SLE reports mixed results but promising disease control benefits
Mycophenolate mofetil reduces severe flares and lower lupus nephritis incidence in patients with early-stage systemic lupus erythematosus
